Experiment 1016660

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationBUKOWSKI,R: VAUGHN,C: BOTTOMLEY,R: CHEN,T:. (1982). PHASE 2 STUDY OF ANGUIDINE IN GASTROINTESTINAL MALIGNANCIES: A SOUTHWEST ONCOLOGY GROUP STUDY.. 66()
Amount utilized
Compound isolated
DiseaseA PHASE II CLINICAL STUDY IN 134 PATIENTS WITH GASTROINTESTINAL MALIGNANCIES. DAILY DOSING FOR 5 DAYS. RESPONSE RAT IN COLON CARCINOMA WAS 22%(4/18 PATIENTS) WITHOUT PREVIOUS CHEMOTHERAPY. NO RESPONSES IN PATIENTS WITH PANCREATIC CANCER(4 PATIENTS) ORGASTRIC CANCER(SIX PATIENTS). TOXIC EFECTS INCLUDED THROMBOCYTOPENIA(19.8%),LEUDOPENIA(18.8%),NAUSEA & VOMITING(49%),HYPOTENSION(37%) AND CONFUSION(12%).
Dose amount3-4.5 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES